NFE2L2 and chronic kidney disease: Nrf2 activation was found to be suppressed in CKD [10,11], Nrf2 polymorphisms have an impact on survival of CKD patients [12], and animals lacking Nrf2 show pathological changes in kidney morphology, loss of kidney function [13], as well as an increased susceptibility to nephrotoxic compounds [14].